Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hookipa Pharma Inc
(NQ:
HOOK
)
2.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hookipa Pharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
April 15, 2024
Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx.
Via
Benzinga
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
April 10, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Beats Revenue for Q4 2023
March 22, 2024
HOOK stock results show that HOOKIPA Pharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
HOOKIPA Pharma: Q4 Earnings Insights
March 22, 2024
Via
Benzinga
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
March 22, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Earnings Preview For HOOKIPA Pharma
November 08, 2023
Via
Benzinga
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
March 06, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
February 13, 2024
Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 01, 2024
Via
Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
January 29, 2024
HOOKIPA Pharma's strategic focus on HB-200 program for HPV16+ HNSCC, infectious disease cure collaboration with Gilead, and recent developments.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
January 29, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades'
January 18, 2024
On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc.
Via
Benzinga
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
January 16, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 22, 2023
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Nasdaq Gains 100 Points; CarMax Earnings Top Views
December 21, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 21, 2023
Via
Benzinga
Crude Oil Moves Lower; Micron Issues Strong Forecast
December 21, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
December 21, 2023
Gilead Sciences Inc (NASDAQ: GILD) announced on Thursday that it has purchased 15 million shares of HOOKIPA Pharma Inc (NASDAQ: HOOK) for approximately $21.25 million,
Via
Benzinga
Dow Jumps 250 Points; US Weekly Jobless Claims Edge Higher
December 21, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.72% to 37,348.90 while the NASDAQ rose 0.96%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Polished.com (POL) Stock Down 38% Today?
December 21, 2023
Polished.com stock is falling on Thursday as investors in POL react to the company's shares undergoing an extreme rally on Wednesday!
Via
InvestorPlace
Why Is Brenmiller Energy (BNRG) Stock Up Today?
December 21, 2023
Brenmiller Energy stock is rising on Thursday as investors celebrate shares of BNRG regaining compliance with listing standards.
Via
InvestorPlace
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
December 21, 2023
Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 21, 2023
It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!
Via
InvestorPlace
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
December 21, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
November 20, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.